Clinical Trial Update: Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial assessing combination chemotherapy with or without ganitumab for previously untreated metastatic pancreatic cancer has been withdrawn from enro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Ganitumab (ganitumab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: WITHDRAWN